Previous 10 | Next 10 |
Numerous studies have shown that psychedelics possess a range of therapeutic benefits that may be useful in treating various conditions. For instance, one study found that administering psilocybin reduced anxiety and depression in patients with cancer. This research also intersects with arti...
We have seen interest in psychedelics increase significantly these last few years, with more studies highlighting the medical benefits these substances possess. Thus far, research has shown that psychedelics such as psilocybin, MDMA and ketamine may help treat mental health conditions, includin...
2023-04-17 05:08:55 ET Summary Numinus announced 2Q23 results that did little to ease investor concerns regarding the rate of cash burn. The company says that it has sufficient working capital to continue for the next twelve months, but this appears somewhat optimistic. Numinu...
A new study has found that ancestors in the Bronze Age frequently indulged in psychedelics. The Bronze Age is a historic period that lasted between 3300 BC–1200 BC. This period got its name from the use of bronze, marking the maiden time people started working with metal. The study fou...
LONDON, April 10, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 22 nd Annual Needham Virtual Healthcare Conf...
2023-04-10 08:55:44 ET Summary COMPASS Pathways is a market leader in the listed psychedelics space and the company has made significant advances over the last few years. COMPASS is burning through cash at a high rate relative to its balance sheet cash resources and investors shou...
A recent study has found that U.S. Special Forces veterans who underwent psychedelic treatment had lower levels of PTSD and alcohol misuse. Military veterans are much more likely to experience mental health conditions such as PTSD and depression, but existing treatments aren’t always eff...
2023-04-02 19:00:00 ET Summary Imran Khan is Executive Director of the Berkeley Center for the Science of Psychedelics. Research behind psychedelics - way more that we don't know than we do. Catalysts and risks. Listen on the go! Subscribe to The Cannabis I...
Ayahuasca is part of a class of chemical compounds called psychedelics that have recently been subject to intense scrutiny from the medical and scientific communities. As drug reform efforts have swept across the country, looser prohibitionist policies have allowed researchers to finally study p...
A microbiome is a group of up to 1,000 microbial and bacterial species that live within your body and play a major role in a variety of functions. Most of the microorganisms in the microbiome are symbiotic and have mutually beneficial relationships with their host. In recent years, increased ...
News, Short Squeeze, Breakout and More Instantly...
LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2024 ending June 30, 2024, a...
New research has determined that psilocybin may impact the brain. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. When ingested, it distorts an individual’s perception of time, among other changes. Researchers have observed that in animals, psilocyb...